We are an innovative investment adviser launched to improve the capital efficiency of the bioscience industry and, where possible, breathe new life into existing development programmes. With a team of leading industry experts, we believe we are ideally placed to unlock trapped cash on balance sheets, support emerging science and technology and assist in the transformation of the global biosciences industry.
We aim to source cash-rich bioscience companies whose market values are either lower than, or close to, their existing cash balances, and where the science is, as yet, unproven.
We will support the purchasing of these ‘fallen angels’, at or near to their current market value for equity in the acquiring entity, and the return of a significant portion of their cash back to existing shareholders of the Company and acquiring entity.
Once acquired, and with the help of the new technologies, we will undertake an assessment of the drug development programme and if there is a path to allow the science to work in a different context. Where this pathway exists, we aim to provide additional support and advice, giving management the opportunity to continue to develop its technology. Once or if revived, we will seek to sell the technology to independent third parties to complete the remaining clinical trials, development and marketing processes. A significant portion of the proceeds from the sale of these technologies will be returned to shareholders and stakeholders in the companies we have acquired.
About us
Stichill Capital Limited is an investment adviser incorporated in England and Wales. Stichill Capital Limited is an appointed representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority. The services offered on this website are intended for professional investors only.
Company Details
- Founded
- -
- Address
- 1 Finsbury Circus, London,ec2m 7sh,united Kingdom
- Industry
- Financial Services
- NAICS
-
Finance and InsuranceMonetary Authorities-Central Bank
- Website
- http://www.stichillcapital.com
- HQ
- London
Stichill Capital Questions
Stichill Capital's website is http://www.stichillcapital.com
Stichill Capital's LinkedIn profile is https://uk.linkedin.com/company/stichill-capital-limited
Stichill Capital's industry is
Financial Services
Stichill Capital's top competitors are
Nysdoccs Recruitment,
Bóthar2med,
Kings Park Capital Llp,
Pbr Real Estate,
Pimlico Capital,
Umaxlife,
Adjuvant Genomics, Inc.,
Cutter Capital Management, Lp,
Alis Biosciences,
Perella Weinberg.
Stichill Capital's categories are Financial Services
Stichill Capital's founding year is 2023
